在COPD中,扩散能力的不成比例损害预测了肺高血压与肺血管阻力增加的肺高血压
Aparna Balasubramanian1, Anna R Hemnes2, Evan L Brittain3
1Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Thorax
|November 27, 2025
概括
使用FEV1/DLCO比率的简单查工具可以识别慢性阻塞性肺病 (COPD) 患者的肺高血压 (PH). 这个比率有助于预测肺血管阻力升高 (PVR),有助于及时治疗和移植转诊.
科学领域:
- 肺部医学 肺部医学
- 心脏病学 心脏病学
- 呼吸系统生理学 呼吸系统生理学
背景情况:
- 肺高血压 (PH) 在COPD中很普遍,但没有定期查.
- 需要一种简单的查工具来检测COPD肺血管阻力升高 (PVR).
- 在COPD中识别PH可以指导PH特异性治疗和肺移植转诊.
研究的目的:
- 确定1秒内强制呼气体积 (FEV1) 与扩散能力 (DLCO) 的比率是否可以预测COPD中的血液动力学模式.
- 评估FEV1/DLCO比率在COPD患者中识别PH与升高的PVR的能力.
主要方法:
- 对411名经过右心导管治疗的COPD患者进行了回顾性分析.
- 多项式模型评估了FEV1/DLCO比率与血液动力学模式之间的关联.
- 接收器运行特征 (ROC) 曲线评估了FEV1/DLCO比率对PH的歧视性性能,其PVR较高.
主要成果:
- 在被纳入的COPD患者中,40%的患者患有PH,PVR升高.
- 增加的FEV1/DLCO比率与PH的可能性更高,PVR升高.
- FEV1/DLCO比率显示了中度的区分性表现 (C-统计0.68-0.72),与心声回声学 (C-统计0.78-0.82) 结合时得到改善.
- 一个FEV1/DLCO值为1.4表明75%的特异性预测PH与升高的PVR.
结论:
- 不成比例地减少的DLCO预测了COPD中PH与升高的PVR.
- FEV1/DLCO比率是评估COPD患者的PH的一个有价值的工具.
- 这个比率可以帮助识别可能从PH特定治疗中受益的COPD患者.
更多相关视频
相关概念视频
Chronic Obstructive Pulmonary Disease-I: Introduction
3.5K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.5K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
COPD: Pathogenesis and Clinical Features
1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.5K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.5K


